Patent Yard Sign in
Canadian application, no grantCanada

Immunization against endogenous molecules

CA 2279826 A1 · Owner: Manns, John G. · Inventors: Harland, Richard; Acres, Stephen D.; Manns, John G.

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

A method is described for immunoneutralization of endogenous molecules in mammalian subjects, wherein an immunogen is administered via injection to the ear. The method is used to elicit an efficient and uniform immune response sufficient to block or suppress the activity of an endogenous hormone in a vaccinated subject, or to target a diseased cell for an immune response.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed February 4, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended February 4, 2018.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 4, 2020.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledFebruary 4, 1998
GrantedNo grant recorded
Term endedFebruary 4, 2018
Patent numberCA 2279826 A1
Classification (IPC)A61K39/00 +2 more

Timeline

Timeline From CIPO dates

1999200120032005200720092011201320152017Application filedFeb 4, 1998Term endedFeb 4, 2018

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.